Optimal medium use for continuous high density perfusion processes

Büntemeyer H, Wallerius C, Lehmann J (1992)
Cytotechnology 9(1-3): 59-67.

Download
OA
Journal Article | Published | English
Author
; ;
Abstract
For maintenance of high cell density in continuous perfusion processes not only feeding with substrates but also removal of inhibitors and toxic waste products are of special interest. High perfusion rates cause large volumes of product containing medium which have to be processed in product isolation. In order to minimize these volumes concentrated feed solutions of optimized medium are used. On the other hand, such media may cause high concentrations of toxic or inhibitory metabolites which can negatively influence cell growth and product formation. Especially, if the spent medium (or special parts of it) is used again after product isolation, the removal or even better the control of inhibitor production is of highest importance. We have developed a continuous fermentation concept and system (continuous medium cycle bioreactor, (MCB) in which both limitation and inhibition effects can be generated to identify special substances as limiting or inhibitory components. With the results from those experiments it was possible to lower the total perfusion rate during serum-free perfusion cultures of hybridoma cells and to obtain an optimal substrate utilization. The advantages for decreasing the production costs (for media, special supplements and product isolation) are obvious. The other aim of this study was to identify secreted metabolic waste products as inhibitor or toxic metabolite.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Büntemeyer H, Wallerius C, Lehmann J. Optimal medium use for continuous high density perfusion processes. Cytotechnology. 1992;9(1-3):59-67.
Büntemeyer, H., Wallerius, C., & Lehmann, J. (1992). Optimal medium use for continuous high density perfusion processes. Cytotechnology, 9(1-3), 59-67.
Büntemeyer, H., Wallerius, C., and Lehmann, J. (1992). Optimal medium use for continuous high density perfusion processes. Cytotechnology 9, 59-67.
Büntemeyer, H., Wallerius, C., & Lehmann, J., 1992. Optimal medium use for continuous high density perfusion processes. Cytotechnology, 9(1-3), p 59-67.
H. Büntemeyer, C. Wallerius, and J. Lehmann, “Optimal medium use for continuous high density perfusion processes”, Cytotechnology, vol. 9, 1992, pp. 59-67.
Büntemeyer, H., Wallerius, C., Lehmann, J.: Optimal medium use for continuous high density perfusion processes. Cytotechnology. 9, 59-67 (1992).
Büntemeyer, Heino, Wallerius, Claus, and Lehmann, Jürgen. “Optimal medium use for continuous high density perfusion processes”. Cytotechnology 9.1-3 (1992): 59-67.
Main File(s)
Access Level
OA Open Access

This data publication is cited in the following publications:
This publication cites the following data publications:

9 Citations in Europe PMC

Data provided by Europe PubMed Central.

A novel control scheme for inducing angiostatin-human IgG fusion protein production using recombinant CHO cells in a oscillating bioreactor.
Wang IK, Hsieh SY, Chang KM, Wang YC, Chu A, Shaw SY, Ou JJ, Ho L., J. Biotechnol. 121(3), 2006
PMID: 16162365
Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process.
Yang JD, Angelillo Y, Chaudhry M, Goldenberg C, Goldenberg DM., Biotechnol. Bioeng. 69(1), 2000
PMID: 10820333
Change in growth kinetics of hybridoma cells entrapped in collagen gel affected by alkaline supply.
Shirai Y, Yamaguchi M, Kobayashi A, Nishi A, Nakamura H, Murakami H., Cytotechnology 14(2), 1994
PMID: 7765240
Growth and interferon-gamma production in batch culture of CHO cells.
Leelavatcharamas V, Emery AN, al-Rubeai M., Cytotechnology 15(1-3), 1994
PMID: 7765954
Catabolic control of hybridoma cells by glucose and glutamine limited fed batch cultures.
Ljunggren J, Haggstrom L., Biotechnol. Bioeng. 44(7), 1994
PMID: 18618848

9 References

Data provided by Europe PubMed Central.


H, 1987
Cell metabolism measurements in culture via microelectronic biosensors.
Grattarola M, Martinoia S, Carlini G, Cambiaso A, Tedesco M, Parodi MT, Ferri G., Cytotechnology 5(Suppl 1), 1991
PMID: 22358955

R, Cytotechnology 7(), 1992

J, 1988

AUTHOR UNKNOWN, 0
Hybridoma growth limitations: the roles of energy metabolism and ammonia production.
Newland M, Greenfield PF, Reid S., Cytotechnology 3(3), 1990
PMID: 1366658

SS, Biotech. Bioeng. 39(), 1992

OW, 1990
Growth limitation in hybridoma cell cultures: the role of inhibitory or toxic metabolites.
Ronning OW, Schartum M, Winsnes A, Lindberg G., Cytotechnology 7(1), 1991
PMID: 1367698

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 1369182
PubMed | Europe PMC

Search this title in

Google Scholar